The Beauty Health Company
10/15/2024 | Press release | Distributed by Public on 10/15/2024 14:19
Management Change/Compensation Form 8 K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Chief Revenue Officer Departure
On October 8, 2024, the Board of Directors (the "Board") of The Beauty Health Company (the "Company") terminated Daniel Watson's employment as Chief Revenue Officer of the Company without cause, effective as of October 14, 2024. Mr. Watson will remain employed with the Company in an advisory role until no later than December 31, 2024. Mr. Watson's termination is not a result of any disagreement with the Company on any matter relating to the Company's financial reporting, operations, policies or practices.
The Company intends to enter into a separation agreement with Mr. Watson as soon as practicable in connection with his separation as Chief Revenue Officer of the Company that will document any applicable payments or benefits to be provided to him in respect of such separation. The Company will file an amendment to this Current Report on Form 8-K within four business days after the parties enter into a definitive separation agreement.